Q2 2011 · 10-Q
Revenue$11.26M$11.26M +22.6% vs Q2 2010+10.0% vs Q1 2011
Net Income-$18.84M-$18.84M N/M vs Q2 2010N/M vs Q1 2011
EPS Diluted-$0.19-$0.19 N/M vs Q2 2010N/M vs Q1 2011
Operating Income-$18,952,000N/M
Operating Cash Flowderived-$18,208,000—
Free Cash Flowderived-$20,207,000—
Margins · derived
Operating margin-168.3%+20.1 pt vs Q2 2010
Net margin-167.3%+19.2 pt vs Q2 2010
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $11.26M | $9.19M |
| Net Income | -$18.84M | -$17.14M |
| EPS Diluted | -$0.19 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR